Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
I-tech | ITECH | Apr 30, 2024 | 45.00 | -0.22 |
Immunovia | IMMNOV | Apr 30, 2024 | 2.03 | -6.24 |
InDex Pharmaceuticals Holding | INDEX | Apr 30, 2024 | 0.39 | -1.50 |
Infant Bacterial Therapeutics B | IBTB | Apr 30, 2024 | 88.20 | -2.00 |
Initiator Pharma | INIT | Apr 30, 2024 | 8.92 | +0.22 |
Intervacc | IVACC | Apr 30, 2024 | 4.21 | +0.72 |
IRLAB Therapeutics A | IRLABA | Apr 30, 2024 | 11.40 | +1.33 |
Isofol Medical | ISOFOL | Apr 30, 2024 | 0.73 | -1.22 |
Kancera | KAN | Apr 30, 2024 | 1.47 | +4.55 |
Klaria Pharma Holding | KLAR | Apr 30, 2024 | 0.38 | +4.17 |
LIDDS | LIDDS | Apr 30, 2024 | 0.17 | +4.29 |
Lipidor | LIPI | Apr 30, 2024 | 0.25 | -2.00 |
Lipigon Pharmaceuticals | LPGO | Apr 30, 2024 | 0.34 | +2.72 |
Lipum | LIPUM | Apr 30, 2024 | 7.00 | +17.65 |
Lumito | LUMITO | Apr 30, 2024 | 1.26 | -3.38 |
Magle Chemoswed | MAGLE | Apr 30, 2024 | 30.20 | +0.67 |
Medivir | MVIR | Apr 30, 2024 | 3.15 | -0.94 |
Mendus AB | IMMU | Apr 30, 2024 | 0.45 | -5.38 |
Miris Holding | MIR | Apr 30, 2024 | 0.18 | +19.33 |
Moberg Pharma | MOB | Apr 30, 2024 | 34.14 | +0.41 |
Modus Therapeutics | MODTX | Apr 30, 2024 | 1.00 | +2.13 |
Nanexa | NANEXA | Apr 30, 2024 | 0.70 | +12.90 |
Nanologica | NICA | Apr 30, 2024 | 5.70 | +1.06 |
NextCell Pharma AB | NXTCL | Apr 30, 2024 | 1.34 | +1.13 |
Nykode Therapeutics | NYKDO | Apr 30, 2024 | 13.05 | 0.00 |
ODI Pharma | ODI | Apr 30, 2024 | 5.70 | 0.00 |
Oncopeptides | ONCO | Apr 30, 2024 | 2.91 | -1.69 |
OncoZenge | ONCOZ | Apr 30, 2024 | 3.72 | +1.36 |
OptiCept Technologies | OPTI | Apr 30, 2024 | 2.50 | -2.53 |
Orexo | ORX | Apr 30, 2024 | 16.90 | +2.67 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.